RxDoctor Payments Data

Terence Williams, DO

Family Medicine · Sand Springs, OKNPI 1487685020

Payments from drug & device makers

$359in general payments, 2019–2025

Across 20 payments — averaging $17.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$86
  • AstraZeneca$60
  • Dexcom, Inc.$42
  • Amgen$40
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$32
  • Boehringer Ingelheim$29
  • plus $70 from 4 others

What the payments were for

  • Food & beverage$359100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$359 in reported general payments places this provider in the 45th percentile of 1,730 family medicine providers in Oklahoma.

See all family medicine providers in Oklahoma

Medicare billing

Part B allowed, 2024
$159,331
Medicare patients
213
Services billed
6,120

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide192$205,672
MounjaroTirzepatide97$121,528
EliquisApixaban131$104,466
Trelegy ElliptaFluticasone/Umeclidin/Vilanter126$102,967
Tresiba Flextouch U-200Insulin Degludec104$102,628
JardianceEmpagliflozin103$93,672
RybelsusSemaglutide49$69,783
FarxigaDapagliflozin Propanediol55$53,305
XareltoRivaroxaban39$40,248
LinzessLinaclotide27$19,099
Breo ElliptaFluticasone/Vilanterol38$16,263
TrulicityDulaglutide12$15,664
Breztri AerosphereBudesonide/Glycopyr/Formoterol19$12,409
MyrbetriqMirabegron19$10,819
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen344$10,569

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$86$104,466131 claims
Boehringer IngelheimJardiance$29$93,672103 claims
AstraZenecaFarxiga, Breztri Aerosphere$60$65,71574 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 1,730 family medicine providers in Oklahoma.

Other family medicine in Sand Springs

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →